Glycolic Acid

Glycolic Acid

SCHEMBL174349

ClCc1ccc2c(c1)CCNCC2.O=C(O)CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.45
HTR2B P41595 2/20 0.45
HTR2A P28223 1/20 0.45
MLNR O43193 8/20 0.44
CYP2D6 P10635 2/20 0.41
ACHE P22303 1/20 0.40
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
MELK Q14680 1/20 0.38
ADCY6 O43306 1/20 0.38
ADCY3 O60266 1/20 0.38
ADCY9 O60503 1/20 0.38
ADCY5 O95622 1/20 0.38
ADCY8 P40145 1/20 0.38
ADCY7 P51828 1/20 0.38
ADCY2 Q08462 1/20 0.38
ADCY1 Q08828 1/20 0.38
ADCY4 Q8NFM4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malonic Acid SCHEMBL173339 0.91 HTR2C (0.45) HTR2CHTR2BHTR2AMLNRCYP2D6
Succinic Acid SCHEMBL174914 0.91 HTR2C (0.45) HTR2CHTR2BHTR2AMLNRCYP2D6
Adipic Acid SCHEMBL173690 0.88 HTR2C (0.42) HTR2CHTR2BHTR2AMLNRCYP2D6
SCHEMBL162032 0.87 HTR2C (0.57) HTR2CHTR2BHTR2AMLNRCYP2D6
Bromide SCHEMBL174563 0.85 HTR2C (0.55) HTR2CHTR2BHTR2AMLNRCYP2D6
Alpha-Ketoglutaric Acid SCHEMBL174620 0.85 MLNR (0.43) HTR2CHTR2BHTR2AMLNRCYP2D6
Sulfuric Acid SCHEMBL174597 0.84 MLNR (0.52) HTR2CHTR2BHTR2AMLNRCYP2D6
Phosphoric Acid SCHEMBL174207 0.84 HTR2C (0.47) HTR2CHTR2BHTR2AMLNRCYP2D6
Aspartic Acid SCHEMBL175033 0.83 MLNR (0.39) HTR2CHTR2BHTR2AMLNRCYP2D6
SCHEMBL174395 0.82 MLNR (0.50) HTR2CHTR2BHTR2AMLNRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611449-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT Arena Pharmaceuticals, Inc. (US) 2013-07-10 EP disclosed
WO-2012030939-A1 ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT ARENA PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed